Skip to main content
SpringerLink
Log in

Cannabis and psychosis

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

There has been considerable debate about the reasons for the association observed between cannabis use and psychosis in both clinical and general population samples. Among the hypotheses proposed to explain the association are the following: 1) common factors explain the cooccurrence; 2 cannabis causes psychosis that would not have occurred in the absence of cannabis use; 3) cannabis precipitates psychosis among persons who were vulnerable to developing the disorders; 4) cannabis use worsens or prolongs psychosis among those who have already developed the disorder; and 5) that persons with psychosis are more likely to become regular or problematic cannabis users than persons without psychosis. This article evaluates the evidence on each of these hypotheses, including recent research on the role of the cannabinoid receptor system in schizophrenia. The evidence suggests that common factors do not explain the comorbidity between cannabis use and psychosis, and it is unlikely that cannabis use causes psychosis among persons who would otherwise not have developed the disorder. The evidence is more consistent with the hypotheses that cannabis use may precipitate psychosis among vulnerable individuals, increase the risk of relapse among those who have already developed the disorder, and may be more likely to lead to dependence in persons with schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Barbee JG, Clark PD, Crapanzo MS, et al.: Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. J Nerv Ment Dis 1989, 177:400–417.

    Article  PubMed  CAS  Google Scholar 

  2. Cohen M, Klein DF: Drug abuse in young psychiatric population. Am J Orthopsychiatry 1970, 40:448–455.

    Article  PubMed  CAS  Google Scholar 

  3. Wheatly M: The prevalence and relevance of substance use in detained schizophrenic patients. J Forensic Sci 1998, 9:114–129.

    Google Scholar 

  4. Mueser KT, Drake RE, Wallach MA: Dual diagnosis: a review of etiological theories. Addict Behav 1998, 23:717–734. A useful review of the evidence that discusses possible mechanisms that underlies the association.

    Article  PubMed  CAS  Google Scholar 

  5. Blanchard J, Brown S, Horan W, Sherwood A: Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin Psychol Rev 2000, 20:207–234. A good, recent review of theory.

    Article  PubMed  CAS  Google Scholar 

  6. Rosenthal R: Is schizophrenia addiction prone? Curr Opin Psychiatry 1998, 11:45–48.

    Article  Google Scholar 

  7. Batel P: Addiction and schizophrenia. Eur Psychiatry 2000, 15:115–122.

    Article  PubMed  CAS  Google Scholar 

  8. Gruber AJ, Pope HG: Cannabis psychotic disorder: does it exist? Am J Addict 1994, 3:7283.

    Article  Google Scholar 

  9. Thornicroft G: Cannabis and psychosis: is there epidemiological evidence for an association? Br J Psychiatry 1990, 157:25–33.

    PubMed  CAS  Google Scholar 

  10. Hall W: Cannabis use and psychosis. Drug Alcohol Rev 1998, 17:433–444. A comprehensive review and evaluation of possible mechanisms explaining comorbidity between cannabis use and psychosis.

    Article  PubMed  CAS  Google Scholar 

  11. Hall W, Degenhardt L: Cannabis use and psychosis: a review of clinical and epidemiological evidence. Australian N Z J Psychiatry 2000, 34:26–34.

    Article  CAS  Google Scholar 

  12. McKay DR, Tennant CC: Is the grass greener? The link between cannabis and psychosis. Med J Australia 2000, 172:284–286.

    PubMed  CAS  Google Scholar 

  13. Phillips P, Johnson S: How does drug and alcohol misuse develop among people with psychotic illness? A literature review. Soc Psychiatry Psychiatr Epidemiol 2001, 36:269–276.

    Article  PubMed  CAS  Google Scholar 

  14. Berkson J: Limitations of the application of fourfold table analysis to hospital data. Biometrics Bull 1946, 2:47–53.

    Article  Google Scholar 

  15. Caron C, Rutter M: Comorbidity in child psychopathology: concepts, issues, and research strategies. J Child Psychology Psychiatry 1991, 32:1063–1080.

    Article  CAS  Google Scholar 

  16. Tien AY, Anthony JC: Epidemiological analysis of alcohol and drug use as risk factors for psychotic experience. J Nerv Ment Dis 1990, 178:473–480.

    PubMed  CAS  Google Scholar 

  17. Degenhardt L, Hall W: The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-being. Psychol Med 2001, 31:659–668. Recent epidemiologic study on comorbidity between use and psychosis.

    Article  PubMed  CAS  Google Scholar 

  18. Hall W, Solowij N, Lemon J: The Health and Psychological Consequences of Cannabis Use. Canberra: Australian Publishing Service; 1994.

    Google Scholar 

  19. Chopra GS, Smith JW: Psychotic reactions following cannabis use in East Indians. Arch Gen Psychiatry 1974, 30:24–27.

    PubMed  CAS  Google Scholar 

  20. Eva J: Cannabis psychosis. Psychiatr Bull 1991, 16:310–311.

    Google Scholar 

  21. Tennant FS, Groesbeck CJ: Psychiatric effects of hashish. Arch Gen Psychiatry 1972, 27:133–136.

    PubMed  Google Scholar 

  22. Carney MWP, Bacelle L, Robinson B: Psychosis after cannabis use. BMJ 1984, 288:1047.

    PubMed  CAS  Google Scholar 

  23. Basu D, Malhotra A, Bhagat A, Varma VK: Cannabis psychosis and acute schizophrenia: a case-control study from India. Eur Addict Res 1999, 5:71–73.

    Article  PubMed  CAS  Google Scholar 

  24. Solomons K, Neppe VM, Kuyl JM: Toxic cannabis psychosis is a valid entity. South African Med J 1990, 78:476–481.

    CAS  Google Scholar 

  25. Bernardson G, Lunne LM: Forty-six cases of psychosis in cannabis abusers. Int J Addict 1972, 7:9–16.

    Google Scholar 

  26. Wylie AS, Scott RTA, Burnett SJ: Psychosis due to "skunk". BMJ 1995, 311:125.

    PubMed  CAS  Google Scholar 

  27. Thornicroft G: Is cannabis psychosis a distinct category? Eur Psychiatry 1992, 7:277–282.

    Google Scholar 

  28. Rolfe M, Tang M, Sabally S, et al.: Psychosis and cannabis abuse in the Gambia: a case-control study. Br J Psychiatry 1993, 163:798–801.

    PubMed  CAS  Google Scholar 

  29. Mathers D, Ghodse A: Cannabis and psychotic illness. Br J Psychiatry 1992, 161:648–653.

    PubMed  CAS  Google Scholar 

  30. Thacore VR, Shukla SRP: Cannabis psychosis and paranoid schizophrenia. Arch Gen Psychiatry 1976, 33:383–386.

    PubMed  CAS  Google Scholar 

  31. Rottanburg D, Robins AH, Ben-Arie O, et al.: Cannabisassociated psychosis with hypomanic features. Lancet 1982, 2:1364–1366.

    Article  PubMed  CAS  Google Scholar 

  32. Imade AGT, Ebie JC: A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatr Scand 1991, 83:134–136.

    PubMed  CAS  Google Scholar 

  33. McGuire P, Jones R, Harvey I, et al.: Cannabis and acute psychosis. Schizophr Res 1994, 13:161–168.

    Article  PubMed  CAS  Google Scholar 

  34. McGuire P, Jones R, Harvey I, et al.: Morbid risk of schizophrenia for relatives of patients with cannabisassociated psychosis. Schizophr Res 1995, 15:277–281.

    Article  PubMed  CAS  Google Scholar 

  35. Cuffel BJ, Heithoff KA, Lawson W: Correlates of patterns of substance abuse among patients with schizophrenia. Hosp Community Psychiatry 1993, 44:247–251.

    PubMed  CAS  Google Scholar 

  36. Thomas H: A community survey of adverse effects of cannabis use. Drug Alcohol Depend 1996, 42:201–207.

    Article  PubMed  CAS  Google Scholar 

  37. Anreasson S, Allebeck P, Rydberg U: Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987, 2:1483–1486.

    Article  Google Scholar 

  38. Degenhardt L, Lynskey M, Hall W: Cohort trends in the age of initiation of drug use in Australia. Australian N Z J Public Health 2000, 24:421–426.

    Article  CAS  Google Scholar 

  39. Degenhardt L, Hall W, Lynskey M: Modeling Some Possible Relationships Between Cannabis Use and Psychosis: NDARC Technical Report No. 121. Sydney: National Drug and Alcohol Research Centre, University of New South Wales; 2001.

    Google Scholar 

  40. Mathers D, Ghodse A, Caan A, Scott S: Cannabis use in a large sample of acute psychiatric admissions. Br J Addict 1991, 86:779–784.

    Article  PubMed  CAS  Google Scholar 

  41. Linszen DH, Dingemans PM, Lenior ME: Cannabis abuse and the course of recent-onset schizophrenia disorders. Arch Gen Psychiatry 1994, 51:273–279.

    PubMed  CAS  Google Scholar 

  42. Allebeck P, Adamsson C, Engstrom A, Rydberg U: Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm county. Acta Psychiatr Scand 1993, 88:21–24.

    PubMed  CAS  Google Scholar 

  43. Hambrecht M, Haefner H: Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Australian N Z J Psychiatry 2000, 34:468–475. A good prospective study of the association between cannabis and schizophrenia.

    Article  CAS  Google Scholar 

  44. Miller P, Lawrie SM, Hodges A, et al.: Genetic liability, illicit drug use, life stress, and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2001, 36:338–342.

    Article  PubMed  CAS  Google Scholar 

  45. Jablensky A, Sartorius N, Ernberg G, et al.: Schizophrenia: manifestations, incidence, and course in different cultures. A World Health Organization 10-country study. Psychol Med Monogr Suppl 1992, 20:1–97.

    PubMed  CAS  Google Scholar 

  46. Negrete JC, Knapp WP, Douglas D, Smith WB: Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med 1986, 16:515–520.

    Article  PubMed  CAS  Google Scholar 

  47. Cleghorn JM, Kaplan RD, Szechtman B, et al.: Substance abuse and schizophrenia: effect on symptoms, but not on neurocognitive function. J Clin Psychiatry 1991, 52:26–30.

    PubMed  CAS  Google Scholar 

  48. Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo_Prieto JR: Cannabis consumption as a prognostic factor in schizophrenia. Br J Psychiatry 1994, 164:679–681.

    Article  PubMed  CAS  Google Scholar 

  49. Drake R, Osher F, Wallach M: Alcohol use and abuse in schizophrenia: a prospective community study. J Nerv Ment Dis 1989, 177:408–414.

    Article  PubMed  CAS  Google Scholar 

  50. Mueser K, Bellack A, Blanchard J: Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychology 1992, 60:845–856.

    Article  CAS  Google Scholar 

  51. Drake R, Osher F, Noordsy D, et al.: Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990, 16:57–67.

    PubMed  CAS  Google Scholar 

  52. Janowsky D, Davis J: Methylphenidate, dextroamphetamine, and levamphetamine. Arch Gen Psychiatry 1976, 33:304–308.

    PubMed  CAS  Google Scholar 

  53. Lieberman J, Kane J, Alvir J: Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology 1987, 415–433.

  54. Hall W, Degenhardt L, Lynskey M: The Health and Psychological Consequences of Cannabis Use. Canberra: Australian Publishing Service; 2001.

    Google Scholar 

  55. Julien R: A Primer of Drug Action: A Concise, Non-technical Guide to the Actions, Uses, and Side Effects of Psychoactive Drugs, edn 9. New York: Worth Publishers; 2001.

    Google Scholar 

  56. Fritzsche M: Are cannabinoid receptor knockout mice animal models for schizophrenia? Med Hypotheses 2001, 56:638–643.

    Article  PubMed  CAS  Google Scholar 

  57. Glass M: The role of cannabinoids in neurodegenerative diseases. Prog Neuropsychopharmacology Biol Psychiatry 2001, 25:743–765.

    Article  CAS  Google Scholar 

  58. Skosnik PD, Spatz-Glenn L, Park S: Cannabis use is associated with schizotypy and attentional dysinhibition. Schizophr Res 2001, 25:743–765.

    Google Scholar 

  59. Leweke FM, Giuffrida A, Wurster U, et al.: Elevated endogenous cannabinoids in schizophrenia. Neuroreport 1999, 1665–1669.

  60. Dean B, Sundram S, Bradbury R, et al.: Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in the density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 2001, 103:9–15.

    Article  PubMed  CAS  Google Scholar 

  61. Voruganti LNP, Slomka P, Zabel P, et al.: Cannabis-induced dopamine release: an in vivo SPECT study. Psychiatry Res 2001, 107:173–177. Recent empiric evidence providing suggestive evidence of the nature of cannabis’ effect on persons with psychosis.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Drug and Alcohol Research Centre, University of New South Wales, 2502, Sydney, Australia

    Louisa Degenhardt PhD & Wayne Hall PhD

Authors
  1. Louisa Degenhardt PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wayne Hall PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Degenhardt, L., Hall, W. Cannabis and psychosis. Curr Psychiatry Rep 4, 191–196 (2002). https://doi.org/10.1007/s11920-002-0026-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-002-0026-5

Keywords

Search

Navigation